Document is current
Any future updates will be listed below
-
Authors
Ulene, Sophie R. https://orcid.org/0000-0002-4259-501X
Wang, Shikun
Cook, Joshua R.
McAuley, Fiona
Wooster, Margaux E.
Faheem, Khadija F.
Varoli, Andrew
McGuinness, Julia E.
Vasan, Neil
Trivedi, Meghna S.
Crew, Katherine D.
Harden, Erik
Law, Cynthia
Hershman, Dawn L.
Accordino, Melissa K.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04473378 at ClinicalTrials.govDocuments that mention this clinical trial
Continuous glucose monitoring and rates of hyperglycemia during chemotherapy for early-stage breast cancer.
https://doi.org/10.1200/jco.2024.42.16_suppl.e24134
Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer
https://doi.org/10.1007/s10549-025-07745-z
-
Funding
Funding for this research was provided by:
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 20 May 2025
First Online: 4 June 2025
Declarations
:
: Author JM has received honoraria from OncLive and WebMD, and has served on advisory boards for Seagen, Gilead, and AstraZeneca. Author EH receives research funding from NCI grant UG1 CA189960 and has been employed by the Globally Healthy Living Foundation. Author MA has served in a consulting role for Disney. All other authors report no competing financial or non-financial interests relevant to the content of this manuscript.
